NewsBenzingaAbbVie e DISCO Pharmaceuticals collaborano su terapie bispecifiche per tumori solidi con gate AND utilizzando la piattaforma DISCOtech; l’accordo prevede 40 milioni di dollari upfront e fino a 2,5 miliardi di dollari in milestone AbbVie e DISCO Pharmaceuticals collaborano su terapie bispecifiche per tumori solidi con gate AND utilizzando la piattaforma DISCOtech; l’accordo prevede 40 milioni di dollari upfront e fino a 2,5 miliardi di dollari in milestone Benzinga 2026.11.19 07:38 (GMT+0) Open on Benzinga Other news Meta Halts Mark Zuckerberg’s New Share Issuance Plan Amid Investor Lawsuit Alleging CEO Pressured Board to Approve It Sunlands Technology Q3 EPS $0.41 Down From $1.31 YoY, Sales $49.500M Down From $73.472M YoY Anthropic IPO to Mint Thousands of Millionaires, With Seven Founders Becoming $10 Billion-Plus Billionaires Futu Holdings Q3 Sales $852.660M Beat $814.820M Estimate ATRenew Q3 Adj. EPS $0.15 Beats $0.10 Estimate, Sales $962.500M Beat $944.000M Estimate GSK’s Velzatinib Receives Japan Orphan Drug Designation For GIST, Supported By StrateGIST 1 Data; Adds To US FDA Fast Track, US, EU ODDs, Phase III Trials Under Way
Meta Halts Mark Zuckerberg’s New Share Issuance Plan Amid Investor Lawsuit Alleging CEO Pressured Board to Approve It
Anthropic IPO to Mint Thousands of Millionaires, With Seven Founders Becoming $10 Billion-Plus Billionaires
GSK’s Velzatinib Receives Japan Orphan Drug Designation For GIST, Supported By StrateGIST 1 Data; Adds To US FDA Fast Track, US, EU ODDs, Phase III Trials Under Way